Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, with Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study)
Abstract We evaluated the association between two-dimensional (2D) echocardiography (echo) determined myocardial contraction fraction (MCF) and adverse cardiovascular outcomes including incident heart failure (HF), atherosclerotic cardiovascular disease (ASCVD) and mortality. The MCF, the ratio of l...
Gespeichert in:
Veröffentlicht in: | The American journal of cardiology 2017-03, Vol.119 (6), p.923-928 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 928 |
---|---|
container_issue | 6 |
container_start_page | 923 |
container_title | The American journal of cardiology |
container_volume | 119 |
creator | Maurer, Mathew S., MD Hoe Koh, William Jen, PhD Bartz, Traci M., MS Vullaganti, Sirish, MD Barasch, Eddy, MD Gardin, Julius M., MD Gottdiener, John S., MD Psaty, Bruce M., MD PhD Kizer, Jorge R., MD, MSc |
description | Abstract We evaluated the association between two-dimensional (2D) echocardiography (echo) determined myocardial contraction fraction (MCF) and adverse cardiovascular outcomes including incident heart failure (HF), atherosclerotic cardiovascular disease (ASCVD) and mortality. The MCF, the ratio of left ventricular (LV) stroke volume (SV) to myocardial volume (MV), is a volumetric measure of myocardial shortening that can distinguish pathologic from physiologic hypertrophy. Using 2D-echo-guided M-mode data from the Cardiovascular Health Study, we calculated MCF among individuals with LV ejection fraction (EF)≥55%, and used Cox models to evaluate its association with incident HF, ASCVD, and all-cause mortality after adjusting for clinical and echo parameters. We assessed whether log2 (SV) and log2 (MV) were consistent with the expected 1:-1 ratio used in the definition of MCF. Among 2147 participants (age 72±5), average MCF was 59±13%. After controlling for clinical and echo variables, each 10% absolute increment in MCF was associated with lower risk of HF (HR=0.88; 95% CI=0.82, 0.94), ASCVD (HR=0.90; 95% CI=0.85, 0.95) and death (HR=0.93; 95% CI=0.89, 0.97). Moreover, the MCF was still significantly associated with ASCVD and mortality, but not HF, after adjustment for percent predicted LV mass. Significant departure from the 1:-1 ratio was not observed for ASCVD or death, but did occur for HF, driven by a stronger association for MV than SV. In conclusion, among older adults without CVD or low LVEF, 2D-echo-guided M-mode-derived MCF was independently associated with lower risk of adverse cardiovascular outcomes, but this ratiometric index may not capture the full relationship that is apparent when its components are modeled separately in the case of HF. |
doi_str_mv | 10.1016/j.amjcard.2016.11.048 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5328842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914916319488</els_id><sourcerecordid>4317442021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-53b1ad5b964aa65de0a6da9083b2af2ad4517cdd187f98701d5f31dc5dc372113</originalsourceid><addsrcrecordid>eNqFUs1uEzEQXiEQDYVHAFniUqRssL3_l6IqNLRSI6QWztbEnm0cnHWwvUF5WN4FLwkFcunF9sjfz3j8JclrRieMsvL9agLrlQSnJjyWE8YmNK-fJCNWV03KGpY9TUaUUp42LG9Okhfer2LJWFE-T054Tass580o-XmLBoK2HbEtCUsk850dVDUYMrVdcCB_384OhzEBT6ZgZB9pqEjr7JrM07lVSC7lcs-19w42y92Y_NBhSa47qRV2gVwhuEBmoE3vcEwuop2zXpq4Bi2j6kDdgh-0HfmoPYJHAp0ic-sCGB125OwWfW-C3xsPDR_RoomJpnehV7t3L5NnLRiPrw77afJ1dvllepXefP50Pb24SWVRZyEtsgUDVSyaMgcoC4UUSgUNrbMFh5aDygtWSaXibNumrihTRZsxJQsls4ozlp0m53vdTb9Yo5I4DM6IjdNrcDthQYv_bzq9FPd2K4qM13XOo8DZQcDZ7z36INbaSzQGOrS9F9G5qvOmjC09Di2qqsg5qyL07RF0ZXvXxUkMgjnNecWyiCr2KBl_wztsH_pmVAxZEytxyJoYsiYYEzFrkffm30c_sP6EKwI-7AEYR7_V6ISXGjuJSjuUQSirH7U4P1KQRndagvmGO_R_XyM8F1TcDYEf8s7KjDV5XWe_AAwUAes</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1874042713</pqid></control><display><type>article</type><title>Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, with Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Maurer, Mathew S., MD ; Hoe Koh, William Jen, PhD ; Bartz, Traci M., MS ; Vullaganti, Sirish, MD ; Barasch, Eddy, MD ; Gardin, Julius M., MD ; Gottdiener, John S., MD ; Psaty, Bruce M., MD PhD ; Kizer, Jorge R., MD, MSc</creator><creatorcontrib>Maurer, Mathew S., MD ; Hoe Koh, William Jen, PhD ; Bartz, Traci M., MS ; Vullaganti, Sirish, MD ; Barasch, Eddy, MD ; Gardin, Julius M., MD ; Gottdiener, John S., MD ; Psaty, Bruce M., MD PhD ; Kizer, Jorge R., MD, MSc</creatorcontrib><description>Abstract We evaluated the association between two-dimensional (2D) echocardiography (echo) determined myocardial contraction fraction (MCF) and adverse cardiovascular outcomes including incident heart failure (HF), atherosclerotic cardiovascular disease (ASCVD) and mortality. The MCF, the ratio of left ventricular (LV) stroke volume (SV) to myocardial volume (MV), is a volumetric measure of myocardial shortening that can distinguish pathologic from physiologic hypertrophy. Using 2D-echo-guided M-mode data from the Cardiovascular Health Study, we calculated MCF among individuals with LV ejection fraction (EF)≥55%, and used Cox models to evaluate its association with incident HF, ASCVD, and all-cause mortality after adjusting for clinical and echo parameters. We assessed whether log2 (SV) and log2 (MV) were consistent with the expected 1:-1 ratio used in the definition of MCF. Among 2147 participants (age 72±5), average MCF was 59±13%. After controlling for clinical and echo variables, each 10% absolute increment in MCF was associated with lower risk of HF (HR=0.88; 95% CI=0.82, 0.94), ASCVD (HR=0.90; 95% CI=0.85, 0.95) and death (HR=0.93; 95% CI=0.89, 0.97). Moreover, the MCF was still significantly associated with ASCVD and mortality, but not HF, after adjustment for percent predicted LV mass. Significant departure from the 1:-1 ratio was not observed for ASCVD or death, but did occur for HF, driven by a stronger association for MV than SV. In conclusion, among older adults without CVD or low LVEF, 2D-echo-guided M-mode-derived MCF was independently associated with lower risk of adverse cardiovascular outcomes, but this ratiometric index may not capture the full relationship that is apparent when its components are modeled separately in the case of HF.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2016.11.048</identifier><identifier>PMID: 28073429</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Alcohol use ; Cardiovascular ; Cardiovascular disease ; Coronary Artery Disease - diagnostic imaging ; Coronary Artery Disease - epidemiology ; Coronary Artery Disease - mortality ; Coronary Artery Disease - physiopathology ; Diabetes ; Echocardiography ; Female ; Fractions ; Heart failure ; Heart Failure - diagnostic imaging ; Heart Failure - epidemiology ; Heart Failure - mortality ; Heart Failure - physiopathology ; Humans ; Hypertension ; Incidence ; Male ; Mortality ; Myocardial Contraction - physiology ; Stroke ; Stroke Volume - physiology ; United States - epidemiology</subject><ispartof>The American journal of cardiology, 2017-03, Vol.119 (6), p.923-928</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Mar 15, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-53b1ad5b964aa65de0a6da9083b2af2ad4517cdd187f98701d5f31dc5dc372113</citedby><cites>FETCH-LOGICAL-c583t-53b1ad5b964aa65de0a6da9083b2af2ad4517cdd187f98701d5f31dc5dc372113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1874042713?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28073429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maurer, Mathew S., MD</creatorcontrib><creatorcontrib>Hoe Koh, William Jen, PhD</creatorcontrib><creatorcontrib>Bartz, Traci M., MS</creatorcontrib><creatorcontrib>Vullaganti, Sirish, MD</creatorcontrib><creatorcontrib>Barasch, Eddy, MD</creatorcontrib><creatorcontrib>Gardin, Julius M., MD</creatorcontrib><creatorcontrib>Gottdiener, John S., MD</creatorcontrib><creatorcontrib>Psaty, Bruce M., MD PhD</creatorcontrib><creatorcontrib>Kizer, Jorge R., MD, MSc</creatorcontrib><title>Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, with Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study)</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Abstract We evaluated the association between two-dimensional (2D) echocardiography (echo) determined myocardial contraction fraction (MCF) and adverse cardiovascular outcomes including incident heart failure (HF), atherosclerotic cardiovascular disease (ASCVD) and mortality. The MCF, the ratio of left ventricular (LV) stroke volume (SV) to myocardial volume (MV), is a volumetric measure of myocardial shortening that can distinguish pathologic from physiologic hypertrophy. Using 2D-echo-guided M-mode data from the Cardiovascular Health Study, we calculated MCF among individuals with LV ejection fraction (EF)≥55%, and used Cox models to evaluate its association with incident HF, ASCVD, and all-cause mortality after adjusting for clinical and echo parameters. We assessed whether log2 (SV) and log2 (MV) were consistent with the expected 1:-1 ratio used in the definition of MCF. Among 2147 participants (age 72±5), average MCF was 59±13%. After controlling for clinical and echo variables, each 10% absolute increment in MCF was associated with lower risk of HF (HR=0.88; 95% CI=0.82, 0.94), ASCVD (HR=0.90; 95% CI=0.85, 0.95) and death (HR=0.93; 95% CI=0.89, 0.97). Moreover, the MCF was still significantly associated with ASCVD and mortality, but not HF, after adjustment for percent predicted LV mass. Significant departure from the 1:-1 ratio was not observed for ASCVD or death, but did occur for HF, driven by a stronger association for MV than SV. In conclusion, among older adults without CVD or low LVEF, 2D-echo-guided M-mode-derived MCF was independently associated with lower risk of adverse cardiovascular outcomes, but this ratiometric index may not capture the full relationship that is apparent when its components are modeled separately in the case of HF.</description><subject>Aged</subject><subject>Alcohol use</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Coronary Artery Disease - diagnostic imaging</subject><subject>Coronary Artery Disease - epidemiology</subject><subject>Coronary Artery Disease - mortality</subject><subject>Coronary Artery Disease - physiopathology</subject><subject>Diabetes</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Fractions</subject><subject>Heart failure</subject><subject>Heart Failure - diagnostic imaging</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - mortality</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Incidence</subject><subject>Male</subject><subject>Mortality</subject><subject>Myocardial Contraction - physiology</subject><subject>Stroke</subject><subject>Stroke Volume - physiology</subject><subject>United States - epidemiology</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUs1uEzEQXiEQDYVHAFniUqRssL3_l6IqNLRSI6QWztbEnm0cnHWwvUF5WN4FLwkFcunF9sjfz3j8JclrRieMsvL9agLrlQSnJjyWE8YmNK-fJCNWV03KGpY9TUaUUp42LG9Okhfer2LJWFE-T054Tass580o-XmLBoK2HbEtCUsk850dVDUYMrVdcCB_384OhzEBT6ZgZB9pqEjr7JrM07lVSC7lcs-19w42y92Y_NBhSa47qRV2gVwhuEBmoE3vcEwuop2zXpq4Bi2j6kDdgh-0HfmoPYJHAp0ic-sCGB125OwWfW-C3xsPDR_RoomJpnehV7t3L5NnLRiPrw77afJ1dvllepXefP50Pb24SWVRZyEtsgUDVSyaMgcoC4UUSgUNrbMFh5aDygtWSaXibNumrihTRZsxJQsls4ozlp0m53vdTb9Yo5I4DM6IjdNrcDthQYv_bzq9FPd2K4qM13XOo8DZQcDZ7z36INbaSzQGOrS9F9G5qvOmjC09Di2qqsg5qyL07RF0ZXvXxUkMgjnNecWyiCr2KBl_wztsH_pmVAxZEytxyJoYsiYYEzFrkffm30c_sP6EKwI-7AEYR7_V6ISXGjuJSjuUQSirH7U4P1KQRndagvmGO_R_XyM8F1TcDYEf8s7KjDV5XWe_AAwUAes</recordid><startdate>20170315</startdate><enddate>20170315</enddate><creator>Maurer, Mathew S., MD</creator><creator>Hoe Koh, William Jen, PhD</creator><creator>Bartz, Traci M., MS</creator><creator>Vullaganti, Sirish, MD</creator><creator>Barasch, Eddy, MD</creator><creator>Gardin, Julius M., MD</creator><creator>Gottdiener, John S., MD</creator><creator>Psaty, Bruce M., MD PhD</creator><creator>Kizer, Jorge R., MD, MSc</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QO</scope><scope>5PM</scope></search><sort><creationdate>20170315</creationdate><title>Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, with Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study)</title><author>Maurer, Mathew S., MD ; Hoe Koh, William Jen, PhD ; Bartz, Traci M., MS ; Vullaganti, Sirish, MD ; Barasch, Eddy, MD ; Gardin, Julius M., MD ; Gottdiener, John S., MD ; Psaty, Bruce M., MD PhD ; Kizer, Jorge R., MD, MSc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-53b1ad5b964aa65de0a6da9083b2af2ad4517cdd187f98701d5f31dc5dc372113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Alcohol use</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Coronary Artery Disease - diagnostic imaging</topic><topic>Coronary Artery Disease - epidemiology</topic><topic>Coronary Artery Disease - mortality</topic><topic>Coronary Artery Disease - physiopathology</topic><topic>Diabetes</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Fractions</topic><topic>Heart failure</topic><topic>Heart Failure - diagnostic imaging</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - mortality</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Incidence</topic><topic>Male</topic><topic>Mortality</topic><topic>Myocardial Contraction - physiology</topic><topic>Stroke</topic><topic>Stroke Volume - physiology</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maurer, Mathew S., MD</creatorcontrib><creatorcontrib>Hoe Koh, William Jen, PhD</creatorcontrib><creatorcontrib>Bartz, Traci M., MS</creatorcontrib><creatorcontrib>Vullaganti, Sirish, MD</creatorcontrib><creatorcontrib>Barasch, Eddy, MD</creatorcontrib><creatorcontrib>Gardin, Julius M., MD</creatorcontrib><creatorcontrib>Gottdiener, John S., MD</creatorcontrib><creatorcontrib>Psaty, Bruce M., MD PhD</creatorcontrib><creatorcontrib>Kizer, Jorge R., MD, MSc</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maurer, Mathew S., MD</au><au>Hoe Koh, William Jen, PhD</au><au>Bartz, Traci M., MS</au><au>Vullaganti, Sirish, MD</au><au>Barasch, Eddy, MD</au><au>Gardin, Julius M., MD</au><au>Gottdiener, John S., MD</au><au>Psaty, Bruce M., MD PhD</au><au>Kizer, Jorge R., MD, MSc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, with Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study)</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2017-03-15</date><risdate>2017</risdate><volume>119</volume><issue>6</issue><spage>923</spage><epage>928</epage><pages>923-928</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Abstract We evaluated the association between two-dimensional (2D) echocardiography (echo) determined myocardial contraction fraction (MCF) and adverse cardiovascular outcomes including incident heart failure (HF), atherosclerotic cardiovascular disease (ASCVD) and mortality. The MCF, the ratio of left ventricular (LV) stroke volume (SV) to myocardial volume (MV), is a volumetric measure of myocardial shortening that can distinguish pathologic from physiologic hypertrophy. Using 2D-echo-guided M-mode data from the Cardiovascular Health Study, we calculated MCF among individuals with LV ejection fraction (EF)≥55%, and used Cox models to evaluate its association with incident HF, ASCVD, and all-cause mortality after adjusting for clinical and echo parameters. We assessed whether log2 (SV) and log2 (MV) were consistent with the expected 1:-1 ratio used in the definition of MCF. Among 2147 participants (age 72±5), average MCF was 59±13%. After controlling for clinical and echo variables, each 10% absolute increment in MCF was associated with lower risk of HF (HR=0.88; 95% CI=0.82, 0.94), ASCVD (HR=0.90; 95% CI=0.85, 0.95) and death (HR=0.93; 95% CI=0.89, 0.97). Moreover, the MCF was still significantly associated with ASCVD and mortality, but not HF, after adjustment for percent predicted LV mass. Significant departure from the 1:-1 ratio was not observed for ASCVD or death, but did occur for HF, driven by a stronger association for MV than SV. In conclusion, among older adults without CVD or low LVEF, 2D-echo-guided M-mode-derived MCF was independently associated with lower risk of adverse cardiovascular outcomes, but this ratiometric index may not capture the full relationship that is apparent when its components are modeled separately in the case of HF.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28073429</pmid><doi>10.1016/j.amjcard.2016.11.048</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2017-03, Vol.119 (6), p.923-928 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5328842 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
subjects | Aged Alcohol use Cardiovascular Cardiovascular disease Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - epidemiology Coronary Artery Disease - mortality Coronary Artery Disease - physiopathology Diabetes Echocardiography Female Fractions Heart failure Heart Failure - diagnostic imaging Heart Failure - epidemiology Heart Failure - mortality Heart Failure - physiopathology Humans Hypertension Incidence Male Mortality Myocardial Contraction - physiology Stroke Stroke Volume - physiology United States - epidemiology |
title | Relation of the Myocardial Contraction Fraction, as Calculated from M-Mode Echocardiography, with Incident Heart Failure, Atherosclerotic Cardiovascular Disease and Mortality (Results from the Cardiovascular Health Study) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A44%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relation%20of%20the%20Myocardial%20Contraction%20Fraction,%20as%20Calculated%20from%20M-Mode%20Echocardiography,%20with%20Incident%20Heart%20Failure,%20Atherosclerotic%20Cardiovascular%20Disease%20and%20Mortality%20(Results%20from%20the%20Cardiovascular%20Health%20Study)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Maurer,%20Mathew%20S.,%20MD&rft.date=2017-03-15&rft.volume=119&rft.issue=6&rft.spage=923&rft.epage=928&rft.pages=923-928&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2016.11.048&rft_dat=%3Cproquest_pubme%3E4317442021%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1874042713&rft_id=info:pmid/28073429&rft_els_id=1_s2_0_S0002914916319488&rfr_iscdi=true |